table_specific

What was the total income for Learningrx from royalty fees as of September 30, 2024?

Learningrx Franchise · 2025 FDD

Answer from 2025 FDD Document

| position of | LearningRx Franchise Corporation | as of | September 30, 2024 and 2023 | , and the results of its | |---|---|---|---|---| | operations and its cash flows for the years then ended in accordance with accounting principles generally | | | | | | accepted in the United States of America. | | | | | ![](_page_60_Picture_0.jp

Source: Item 23 — RECEIPT (FDD pages 54–209)

What This Means (2025 FDD)

According to Learningrx's 2025 Franchise Disclosure Document, the company's total income from royalty fees for the year ending September 30, 2024, was $1,192,359. This figure represents the income Learningrx received from its franchisees based on a percentage of their gross revenues. Royalty fees are a standard component of franchise agreements, providing ongoing revenue to the franchisor in exchange for the continued use of the Learningrx brand, system, and support.

For a prospective Learningrx franchisee, understanding the franchisor's revenue streams is crucial. Royalty fees typically fund the ongoing support, training, and development that Learningrx provides to its franchisees. A healthy royalty income for the franchisor often indicates a stable and well-supported franchise system.

It's also worth noting that Learningrx's royalty fee income remained relatively stable compared to the previous year. The royalty fees for the year ending September 30, 2023, were $1,192,063. This indicates a consistent revenue stream from royalties for Learningrx.

When evaluating this information, a potential franchisee should consider how Learningrx uses these royalty fees to support the franchise network and what services and resources are provided in return for these fees. It is also important to compare these figures with those of other similar franchises to assess the competitiveness and financial health of Learningrx.

Disclaimer: This information is extracted from the 2025 Franchise Disclosure Document and is provided for research purposes only. It does not constitute legal or financial advice. Consult with a franchise attorney before making any investment decisions.